Search
Search Results
##search.searchResults.foundPlural##
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6808PDF: 3644HTML: 753 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1829PDF: 715HTML: 2106Untitled: 215Untitled: 152Untitled: 171Untitled: 154Untitled: 163Untitled: 178Untitled: 183 -
“Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency. Hemolysis by Hemolysis and G6PD deficiency.
1265PDF: 979HTML: 336 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3364PDF: 1279HTML: 2215Fi.1 Gritti.Rambaldi: 205 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3684PDF: 1437HTML: 182 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3267PDF: 1236HTML: 8104 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7945PDF: 4121HTML: 7363 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
995PDF: 984Suppl. Files: 635HTML: 126 -
Azacytidine failure revisited: an appraisal based on real life data from the MDS registry of the Hellenic Myelodysplastic Syndrome Study Group (HMDS). Azacytidine failure revisited
1081PDF: 842HTML: 238 -
FEASIBILITY AND OUTCOME OF FIRST-LINE AUTOTRANSPLANT-BASED TREATMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED > 65 YEARS: MONOCENTRIC RETROSPECTIVE REAL-WORLD ANALYSIS Outcomes of ASCT in NDMM elderly fit patients
1051PDF: 617Html: 148 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
868PDF: 475HTML: 124Suppl. Files: 312 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1713PDF: 834HTML: 146 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1965PDF: 746HTML: 694 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3376PDF: 1292HTML: 1861Fig.1: 199Fig. 2: 207 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1906PDF: 1214HTML: 237







